MAPT and Alzheimer disease: This case-control study assesses concentrations of Klotho protein in cerebrospinal fluid and plasma among cognitively healthy controls and patients with Alzheimer disease (AD) and correlates these findings with KL-VS heterozygosity status and amyloid and tau burden.